BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 16890804)

  • 21. c-MYC repression of promoter activity through core promoter elements.
    Lucas JM; Wilkie NM; Lang JC
    Biochem Biophys Res Commun; 1993 Aug; 194(3):1446-52. PubMed ID: 8352803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 9-N-Substituted berberine derivatives: stabilization of G-quadruplex DNA and down-regulation of oncogene c-myc.
    Ma Y; Ou TM; Hou JQ; Lu YJ; Tan JH; Gu LQ; Huang ZS
    Bioorg Med Chem; 2008 Aug; 16(16):7582-91. PubMed ID: 18674916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular modeling and biophysical analysis of the c-MYC NHE-III1 silencer element.
    Cashman DJ; Buscaglia R; Freyer MW; Dettler J; Hurley LH; Lewis EA
    J Mol Model; 2008 Feb; 14(2):93-101. PubMed ID: 18087730
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design and synthesis of an expanded porphyrin that has selectivity for the c-MYC G-quadruplex structure.
    Seenisamy J; Bashyam S; Gokhale V; Vankayalapati H; Sun D; Siddiqui-Jain A; Streiner N; Shin-Ya K; White E; Wilson WD; Hurley LH
    J Am Chem Soc; 2005 Mar; 127(9):2944-59. PubMed ID: 15740131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The flanking sequence contributes to the immobilisation of spermine at the G-quadruplex in the NHE (nuclease hypersensitivity element) III1 of the c-Myc promoter.
    Keniry MA; Owen EA
    FEBS Lett; 2014 May; 588(10):1949-54. PubMed ID: 24735723
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stabilization of G-quadruplex DNA and down-regulation of oncogene c-myc by quindoline derivatives.
    Ou TM; Lu YJ; Zhang C; Huang ZS; Wang XD; Tan JH; Chen Y; Ma DL; Wong KY; Tang JC; Chan AS; Gu LQ
    J Med Chem; 2007 Apr; 50(7):1465-74. PubMed ID: 17346034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of the equilibrium between G-quadruplex and duplex DNA in promoter of human c-myc oncogene by a pyrene derivative.
    Zhang Z; He X; Yuan G
    Int J Biol Macromol; 2011 Dec; 49(5):1173-6. PubMed ID: 21683090
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-affinity homologous peptide nucleic acid probes for targeting a quadruplex-forming sequence from a MYC promoter element.
    Roy S; Tanious FA; Wilson WD; Ly DH; Armitage BA
    Biochemistry; 2007 Sep; 46(37):10433-43. PubMed ID: 17718513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of cell proliferation by quindoline derivative (SYUIQ-05) through its preferential interaction with c-myc promoter G-quadruplex.
    Ou TM; Lin J; Lu YJ; Hou JQ; Tan JH; Chen SH; Li Z; Li YP; Li D; Gu LQ; Huang ZS
    J Med Chem; 2011 Aug; 54(16):5671-9. PubMed ID: 21774525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Furan based cyclic homo-oligopeptides bind G-quadruplex selectively and repress c-MYC transcription.
    Agarwal T; Roy S; Chakraborty TK; Maiti S
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4346-9. PubMed ID: 20615700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of loop orientation on quadruplex-TMPyP4 interaction.
    Arora A; Maiti S
    J Phys Chem B; 2008 Jul; 112(27):8151-9. PubMed ID: 18553964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. c-MYC promoter G-quadruplex formed at the 5'-end of NHE III1 element: insights into biological relevance and parallel-stranded G-quadruplex stability.
    Mathad RI; Hatzakis E; Dai J; Yang D
    Nucleic Acids Res; 2011 Nov; 39(20):9023-33. PubMed ID: 21795379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disubstituted 1,8-dipyrazolcarbazole derivatives as a new type of c-myc G-quadruplex binding ligands.
    Chen WJ; Zhou CX; Yao PF; Wang XX; Tan JH; Li D; Ou TM; Gu LQ; Huang ZS
    Bioorg Med Chem; 2012 May; 20(9):2829-36. PubMed ID: 22484007
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platination of telomeric sequences and nuclease hypersensitive elements of human c-myc and PDGF-A promoters and their ability to form G-quadruplexes.
    Viglasky V
    FEBS J; 2009 Jan; 276(2):401-9. PubMed ID: 19054066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. c-myc Suppression in Burkitt's lymphoma cells.
    Simonsson T; Henriksson M
    Biochem Biophys Res Commun; 2002 Jan; 290(1):11-5. PubMed ID: 11779125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel interaction of the Z-DNA binding domain of human ADAR1 with the oncogenic c-Myc promoter G-quadruplex.
    Kang HJ; Le TV; Kim K; Hur J; Kim KK; Park HJ
    J Mol Biol; 2014 Jul; 426(14):2594-604. PubMed ID: 24813121
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of a Family of Genomic Sequences Which Interact Specifically with the c-MYC Promoter to Regulate c-MYC Expression.
    Rezzoug F; Thomas SD; Rouchka EC; Miller DM
    PLoS One; 2016; 11(8):e0161588. PubMed ID: 27551915
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanistic studies for the role of cellular nucleic-acid-binding protein (CNBP) in regulation of c-myc transcription.
    Chen S; Su L; Qiu J; Xiao N; Lin J; Tan JH; Ou TM; Gu LQ; Huang ZS; Li D
    Biochim Biophys Acta; 2013 Oct; 1830(10):4769-77. PubMed ID: 23774591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cellular nucleic-acid-binding protein, a transcriptional enhancer of c-Myc, promotes the formation of parallel G-quadruplexes.
    Borgognone M; Armas P; Calcaterra NB
    Biochem J; 2010 May; 428(3):491-8. PubMed ID: 20394585
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel factor distinct from E2F mediates C-MYC promoter activation through its E2F element during exit from quiescence.
    Alvaro-Blanco J; Martínez-Gac L; Calonge E; Rodríguez-Martínez M; Molina-Privado I; Redondo JM; Alcamí J; Flemington EK; Campanero MR
    Carcinogenesis; 2009 Mar; 30(3):440-8. PubMed ID: 19126644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.